Adynxx

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Adynxx and buy or sell other stocks, ETFs, and their options commission-free!

About ADYX

Adynxx, Inc. is a clinical stage biopharmaceutical company, which engages in the manufacture, development, and sale of novel, disease-modifying products for the treatment of pain and inflammation. The company was founded by Julien Mamet in 2007 and is headquartered in San Francisco, CA. 

CEO
Rick Orr
CEORick Orr
Employees
6
Employees6
Headquarters
San Francisco, California
HeadquartersSan Francisco, California
Founded
2007
Founded2007
Employees
6
Employees6

ADYX Key Statistics

Market cap
580.80
Market cap580.80
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
Average volume
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.0002
52 Week high$0.0002
52 Week low
$0.00
52 Week low$0.00

Stock Snapshot

With a market cap of 580.8, Adynxx(ADYX) trades at $0.00.

On 2026-02-09, Adynxx(ADYX) stock opened at —, reached a high of —, and a low of —.

Adynxx(ADYX) shares are trading with a volume of 0.

During the past year, Adynxx(ADYX) stock moved between $0.00 at its lowest and $0.00 at its peak.

During the past year, Adynxx(ADYX) stock moved between $0.00 at its lowest and $0.00 at its peak.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.